Meeting
2022 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA-based molecular residual disease detection and recurrence monitoring in patients with advanced or metastatic anal squamous cell carcinoma.
Authors
Georges Azzi
Holy Cross Medical Group, Michael and Dianne Bienes Comprehensive Cancer Center, Fort Lauderdale, FL
Georges Azzi , Mehrad Tavallai , Gregory P. Botta , Mohamedtaki Abdulaziz Tejani , Diana L. Hanna , Adham Adel Jurdi , Griffin Budde , Shifra Krinshpun , Minu Maninder , Vasily N. Aushev , Perry Olshan , Paul R. Billings , Alexey Aleshin , Pashtoon Murtaza Kasi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Translational Research
DOI
10.1200/JCO.2022.40.4_suppl.006
Abstract #
6
Poster Bd #
A7
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Serial circulating tumor DNA monitoring for predicting treatment response and prognosis in patients with pancreatic cancer.
First Author: Jongchan Lee
First Author: Jacqueline Shaw
Poster
2020 ASCO Virtual Scientific Program
Tumor-informed assessment of molecular residual disease and its incorporation into practice for patients with early and advanced-stage colorectal cancer (CRC-MRD Consortia).
First Author: Pashtoon Murtaza Kasi
Poster
2018 Gastrointestinal Cancers Symposium
SM-88 therapy in patients with advanced or metastatic pancreatic cancer.
First Author: Steve Hoffman